Not provided
| ID | Type | Description | Link |
|---|---|---|---|
| 2020-002945-41 | EudraCT Number |
Not provided
Not provided
Slow recruitment due to covid-19 and organizational changes.
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
A prospective double-blind, randomized controlled trial investigating the effect of a single-dose of intraoperative methadone on postoperative pain and opioid consumption in 96 children undergoing open urological surgery.
Treatment of postoperative pain is a challenge in younger children undergoing outpatient surgery. After discharge parents must assess pain intensity and administer analgesics, including opioids, as per needed. It has been shown that parents often hesitate to administer analgesics. The result is unrelieved pain that negatively affects the whole family and increases the risk of unscheduled contacts with healthcare professionals.
In children, methadone has shown a half-life of 19,2 +/-13,6 hours. Regarding outpatient surgery, methadone is an opioid with unique pharmalogical properties that may be advantageous. A single-dose of this long acting opioid administered perioperatively could provide a stable analgesia and potentially reduce the need for shorter-acting opioids in the PACU and at home.
Not provided
Not provided
Not provided
Not provided
| Label | Type | Description | Intervention Names |
|---|---|---|---|
| Placebo | Placebo Comparator | A 5 ml syringe with saline will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia. |
|
| Methadone | Experimental | A 5 ml syringe with 1 mg/ml of methadone will be prepared and study drug will be administered as intravenous bolus dose (0.1 mg/kg). The study drug will be administered at induction of anesthesia. |
|
| Name | Type | Description | Arm Group Labels | Other Names |
|---|---|---|---|---|
| Methadone Hydrochloride | Drug | Single dose, intravenous bolus, 0,1 mg/kg administered at induction of anesthesia. |
|
| Measure | Description | Time Frame |
|---|---|---|
| Patients consumption of analgesics in the PACU. | Within the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours). | 3 hours |
| Pain intensity (highest score) | FLACC-score - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score. Within the first 3 hours from extubation (or until discharge from PACU, if discharged before 3 hours) | 3 hours |
| Measure | Description | Time Frame |
|---|---|---|
| Readiness to discharge | Time for readiness to discharge from PACU assessed by PACU nurse. | 6 hours |
| Patients need of supplemental oxygen in PACU | Need of supplemental oxygen within the first 3 hours after extubation,(or until discharge from PACU, if discharged before 3 hours) |
| Measure | Description | Time Frame |
|---|---|---|
| FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, at home | Parental experience with assessment of the FLACC-score at home following discharge. | 48 hours |
Inclusion Criteria:
Children scheduled for open urological surgery at the Outpatient Clinic at Aarhus University Hospital.
Exclusion Criteria:
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Facility | Status | City | State | ZIP | Country | Contacts |
|---|---|---|---|---|---|---|
| Aarhus University Hospital | Aarhus | 8200 | Denmark |
Not provided
Not provided
Not provided
Not provided
Not provided
Not provided
| Type | Includes Protocol | Includes SAP | Includes ICF | Document Label | Document Date | Document Uploaded Date | Document File Name |
|---|---|---|---|---|---|---|---|
| Prot_SAP | Yes | Yes | No | Study Protocol and Statistical Analysis Plan | Feb 22, 2024 | Feb 23, 2024 | Prot_SAP_000.pdf |
Not provided
| ID | Term |
|---|---|
| D059787 | Acute Pain |
| D010149 | Pain, Postoperative |
| ID | Term |
|---|---|
| D010146 | Pain |
| D009461 | Neurologic Manifestations |
| D012816 | Signs and Symptoms |
| D013568 | Pathological Conditions, Signs and Symptoms |
Not provided
Not provided
| ID | Term |
|---|---|
| D008691 | Methadone |
| D012965 | Sodium Chloride |
| ID | Term |
|---|---|
| D007659 | Ketones |
| D009930 | Organic Chemicals |
| D002712 | Chlorides |
| D006851 | Hydrochloric Acid |
Not provided
Not provided
Randomized controlled trial.
Not provided
Not provided
Randomisation and study medication will be handled by the hospital pharmacy. All research team members, caregiving clinicians and enrolled patients will be blinded to the study allocation arms and the randomisation list will be concealed until all statistical analyses are made.
| Placebo | Other | Single dose, intravenous bolus. Administered as the experimental arm. |
|
|
| 3 hours |
| Awakenings during the first night after discharge. | Parents will answer whether the child have been awake and whether they believe the awakening(s) where due to pain. | 24 hours |
| Pain intensity the first postoperative day | Assessed by parents, 3 FLACC-scores - Face, Legs, Activity, Cry og Consolability, 0-10, where 10 is the highest pain score, during the first postoperative day. | 48 hours |
| Analgesic consumption following discharge until evening on the first postoperative day | From discharge until 8 PM the first day following surgery. Collected by parents. | 36 hours |
| Unscheduled parental contacts to the hospital | Parental contacts to hospital regarding pain and/or analgesics until 4 days following surgery. | 4 days |
| D011183 | Postoperative Complications |
| D010335 | Pathologic Processes |
| D017606 |
| Chlorine Compounds |
| D007287 | Inorganic Chemicals |
| D017670 | Sodium Compounds |